M2-macrophages and Mesenchymal Cells therapy(Peaches Biotech)

N/A

Report date: 2024/11/14 20:00:08

Base Information

Drug NameM2-macrophages and Mesenchymal Cells therapy(Peaches Biotech)

Drug Alias NamePRS CK STORM

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Macrophages therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultRespiratory Syncytial Virus Infections +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesPeaches Biotech

China Registration ClassN/A

Develop Information

Active CompaniesPeaches Biotech

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultRespiratory Syncytial Virus Infections +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A